Cancer Biology & Medicine2026，Vol.23Issue(1)：P.30-41,12.DOI:10.20892/j.issn.2095-3941.2025.0198
Innovative cross-intervention:copper ions and metabolic pathways in cancer therapy
Lili Niu 1Wei Su 2Lixia Ju 3Jun Xiang 4Zhou Yang 5Bing Yao6
作者信息
- 1. Department of Integrative Medicine,Shanghai Pulmonary Hospital,Thoracic Cancer Institute,Tongji University School of Medicine,Shanghai 200433,China Department of Cancer Biology,Gastroenterology and Hepatology,Mayo Clinic,Jacksonville,Florida 32224,USA
- 2. Department of Medical Oncology,Fudan University Shanghai Cancer Center,Shanghai,China Department of Oncology,Shanghai Medical College,Fudan University,Shanghai 200032,China
- 3. Department of Integrative Medicine,Shanghai Pulmonary Hospital,Thoracic Cancer Institute,Tongji University School of Medicine,Shanghai 200433,China
- 4. Department of Oncology,Shanghai Medical College,Fudan University,Shanghai 200032,China Department of Head and Neck Surgery,Fudan University Shanghai Cancer Center,Shanghai,China
- 5. Department of Medical Oncology,Shanghai East Hospital,Tongji University School of Medicine,Shanghai 200120,China
- 6. National Experimental Teaching Center of Basic Medical Science,Department of Medical Genetics,School of Basic Medical Sciences,Nanjing Medical University,Nanjing 211166,China Department of General Surgery,The Affiliated Taizhou People’s Hospital of Nanjing Medical University,Taizhou School of Clinical Medicine,Nanjing Medical University,Nanjing 211166,China State Key Laboratory Cultivation Base of Biomarkers for Cancer Precision Prevention and Treatment,Collaborative Innovation Center for Cancer Personalized Medicine,NHC Key Laboratory of Antibody Technique,Jiangsu Province Engineering Research Center of Antibody Drug,Nanjing Medical University,Nanjing 211166,China
- 折叠
摘要
关键词
Copper homeostasis/cuproptosis/tumor metabolism/nanotherapy/hypoxia resistance分类
医药卫生引用本文复制引用
Lili Niu,Wei Su,Lixia Ju,Jun Xiang,Zhou Yang,Bing Yao..Innovative cross-intervention:copper ions and metabolic pathways in cancer therapy[J].Cancer Biology & Medicine,2026,23(1):P.30-41,12.基金项目
supported by the National Natural Science Foundation of China(Grant Nos.82303206,82372749,and 82072951) （Grant Nos.82303206,82372749,and 82072951）
Science and Technology Commission of Shanghai Municipality(Grant Nos.20Y11914300 and 22Y21900100) （Grant Nos.20Y11914300 and 22Y21900100）
Shanghai Anticancer Association(Grant No.SACAAX202213) （Grant No.SACAAX202213）
Major Research Projects of Taizhou Clinical Medical College(Grant No.TZKY20230308) （Grant No.TZKY20230308）
Natural Science Foundation in University of Jiangsu Province(Grant No.BK20231261). （Grant No.BK20231261）
